相关实验视频

Updated: Jun 23, 2025

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

外体作为质瘤免疫治疗中的药物输送系统

Xinqing Hao^1,2, Shiming Wang³, Liang Wang^1,2

¹Stem Cell Clinical Research Center, The First Affiliated Hospital of Dalian Medical University, No. 193 Lianhe Road, Dalian, Liaoning, 116011, China.

Journal of nanobiotechnology

|June 18, 2024

概括

外体有望通过克服药物输送和免疫激活挑战来改善质瘤免疫疗法. 本综述探讨了基于外体的策略,以提高癌症治疗效率,克服免疫抑制瘤微环境.

科学领域:

在瘤学瘤学.
纳米技术纳米技术
免疫学免疫学免疫学

背景情况:

癌症免疫疗法对许多癌症有显著的益处.
质瘤免疫疗法的有效性受到药物输送不良和免疫激活不足的限制.
作为药物载体,外体具有优势,包括低毒性和良好的生物相容性.

研究的目的:

审查基于外体的药物输送系统,用于质瘤免疫治疗.
介绍目前质瘤免疫疗法的挑战.
讨论增强免疫性和逆转免疫抑制瘤微环境的策略,使用外体.

主要方法:

用于质瘤免疫治疗的基于外体的药物递送系统的文献综述.
讨论准备和应用策略.
分析临床翻译方面的挑战.

主要成果:

外体细胞可能通过改善药物输送和免疫激活来增强质瘤免疫疗法.
基于外体的系统可以被设计成增加免疫性.
外体细胞可能有助于逆转质瘤中免疫抑制性瘤微环境.

结论:

外体代表了一个有前途的平台,用于推进质瘤免疫疗法.
需要进一步的研究和开发,以临床翻译基于外体细胞的疗法.
本综述为利用外体细胞作为药物载体在质瘤治疗中提供了指导.

关键词:

药物输送系统是药物输送系统.外基因组是外基因组的组成部分.质瘤是一种质瘤.免疫治疗是一种免疫疗法.

更多相关视频

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Stereotactic Adoptive Transfer of Cytotoxic Immune Cells in Murine Models of Orthotopic Human Glioblastoma Multiforme Xenografts

Published on: September 1, 2018

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Glioblastoma Relapse Post-Resection Model for Therapeutic Hydrogel Investigations

Published on: February 24, 2023

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.